Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 16:2022:6057017.
doi: 10.1155/2022/6057017. eCollection 2022.

PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma

Affiliations
Review

PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma

Jin Zhao et al. Contrast Media Mol Imaging. .

Abstract

The aim of this study was to investigate the clinical value of positron emission tomography/computerized tomography scanning (PET/CT) in the evaluation of the effect of allogeneic hematopoietic stem cell transplantation in the treatment of T lymphoblastic lymphoma. 12 relevant research articles were collected through layer-by-layer screening in large databases such as Pubmed, Baidu Scholar, and China How Net, and analyzed and summarized using indicators such as progression-free survival (PFS), overall survival (OS), hazard ratio (HR), maximum standardized uptake value (SUV max), total metabolic tumor volume (TMTV), total lesion glycolysis (TLG), elevated lactate dehydrogenase (LDH), and β2-microglobulin (β2-MG). The results showed that before treatment, 18F-FDG PET/CT baseline diagnosis could accurately stage the patients; during treatment, 18F-FDG PET/CT detection could provide effective treatment information; and after treatment, complications were found during 18F-FDG PET/CT detection. In summary, 18F-FDG PET/CT can monitor and evaluate treatment prognosis at baseline, middle, and late stages, and 18F-FDG PET/CT has become an indispensable and important examination technique in clinical work.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Classification of lymphoblastic lymphoma.
Figure 2
Figure 2
The flow chart of a literature search.
Figure 3
Figure 3
Preparation and application process of the 18F-FDG drug.
Figure 4
Figure 4
The imaging principle of 18F-FDG PET/CT.

Similar articles

References

    1. Ostrowska B., Rymkiewicz G., Chechlinska M., et al. Prognostic value of the immunological subtypes of adolescent and adult T-cell lymphoblastic lymphoma; an ultra-high-risk pro-T/CD2(-) subtype. Cancers . 2021;13(8):p. 1911. doi: 10.3390/cancers13081911. - DOI - PMC - PubMed
    1. Meng X., Min Q., Wang J. Y. B cell lymphoma. Advances in Experimental Medicine and Biology . 2020;1254:161–181. doi: 10.1007/978-981-15-3532-1_12. - DOI - PubMed
    1. Montes-Torres A., Llamas-Velasco M., Capusan T. M., Aguado B., Adrados M. Cutaneous involvement as the first manifestation of T-lymphoblastic lymphoma and review of the literature. Journal of Cutaneous Pathology . 2019;46(5):372–375. doi: 10.1111/cup.13431. - DOI - PubMed
    1. Teachey D. T., O’Connor D. How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children. Blood . 2020 16;135(3):159–166. doi: 10.1182/blood.2019001557. - DOI - PMC - PubMed
    1. Richard-Carpentier G., Jabbour E., Short N. J., et al. Clinical experience with venetoclax combined with chemotherapy for relapsed or refractory T-cell acute lymphoblastic leukemia. Clinical Lymphoma, Myeloma & Leukemia . 2020;20(4):212–218. doi: 10.1016/j.clml.2019.09.608. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources